Direct-to-consumer genetic testing services: What are the medical benefits?

European Journal of Human Genetics

Volumn 20, Issue 5, 2012, Pages 483-

  Frebourg, Thierry ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; BREAST CANCER; CANCER RISK; CLINICAL PRACTICE; COLORECTAL CANCER; DISTRESS SYNDROME; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INHERITANCE; MEDICAL GENETICS; NOTE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENOME, HUMAN; HUMANS; MALE; NEOPLASMS;

EID: 84859897040     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.229     Document Type: Note

References (2)

1. Bloss CS, Darst BF, Topol EJ, Schork NJ: Direct-toconsumer personalized genomic testing. Hum Mol Genet 2011; 20: R132-R141.
2. Heald B, Edelman E, Eng C: Prospective comparison of family medical history to personal genome screening for risk assessment of common cancers. Eur J Hum Genet 2012; 20: 547-551.